Companhia Siderúrgica Nacional (SID)
| Market Cap | 1.57B -23.0% |
| Revenue (ttm) | 8.71B +0.9% |
| Net Income | -507.04M |
| EPS | -0.38 |
| Shares Out | 1.33B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,524,939 |
| Open | 1.160 |
| Previous Close | 1.210 |
| Day's Range | 1.140 - 1.180 |
| 52-Week Range | 0.837 - 2.200 |
| Beta | 1.40 |
| Analysts | Sell |
| Price Target | 1.15 (0.0%) |
| Earnings Date | Nov 10, 2026 |
About SID
Companhia Siderúrgica Nacional, together with its subsidiaries, operates as an integrated steel producer in Brazil and internationally. It operates through five segments: Steel Industry, Mining, Logistics, Energy, and Cement. The Steel Segment offers produce and sells of flat and long steel. The Mining Segment engages in extraction, processing and marketing of iron ore, tin, limestone, and dolomite. The Logistics Segment supplies railways, port concessions, and road fleet. The Cement Segment produces and sells bagged and bulk cement, as well as... [Read more]
Financial Performance
In 2025, SID's revenue was 44.80 billion, an increase of 2.54% compared to the previous year's 43.69 billion. Losses were -2.00 billion, -22.74% less than in 2024.
Financial numbers in BRL Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for SID stock is "Sell." The 12-month stock price target is $1.15, which is no change of 0.00% from the latest price.
News
Tuesday Sector Laggards: Non-Precious Metals & Non-Metallic Mining, Television & Radio Stocks
In trading on Tuesday, non-precious metals & non-metallic mining shares were relative laggards, down on the day by about 2.2%. Helping drag down the group were shares of Companhia Siderurgica Nacional...
CSN price target lowered to R$5 from R$5.50 at HSBC
HSBC analyst Jonathan Brandt lowered the firm’s price target on CSN (SID) to R$5 from R$5.50 and keeps a Hold rating on the shares. The firm says the Latin America…
National Steel Q2 Earnings Call Highlights
National Steel NYSE: SID, also known as CSN, reported higher consolidated EBITDA in the second quarter of 2026, supported by improved commercial performance across its steel, cement, logistics and ene...
Companhia Siderúrgica Nacional Earnings Call Transcript: Q2 2026
EBITDA grew 5% year-over-year and quarter-over-quarter, driven by operational improvements and strong segment results in steel, cement, logistics, and energy. Asset sales and working capital release supported positive cash flow and deleveraging, with further improvements expected in H2.
Companhia Siderúrgica Nacional Earnings release: Q2 2026
Companhia Siderúrgica Nacional released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Companhia Siderúrgica Nacional Quarterly report: Q2 2026
Companhia Siderúrgica Nacional has published its Q2 2026 quarterly earnings report on August 13, 2026.
Companhia Siderúrgica Nacional Slides: Q2 2026
Companhia Siderúrgica Nacional has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
Announcement of Final Results of Private Exchange Offer for CSN Inova Ventures' Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation
São Paulo, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Companhia Siderúrgica Nacional (“CSN”) (NYSE: SID) announced today the final results of the offer to exchange (the “Exchange Offer”) conducted by its subsi...
Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures' Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation
São Paulo, July 30, 2026 (GLOBE NEWSWIRE) -- Companhia Siderúrgica Nacional (“CSN”) (NYSE: SID) announced today that its subsidiary, CSN Inova Ventures (formerly CSN Islands XI Corp.) (the “Issuer”), ...
See How Companhia Siderurgica Nacional Ranks Among Analysts' Top Metals Picks
A study of analyst recommendations at the major brokerages shows that Companhia Siderurgica Nacional (Symbol: SID) is the #33 broker analyst pick, on average, out of the 50 stocks making up the Metals...
National Steel Q1 Earnings Call Highlights
National Steel NYSE: SID, the Brazilian steelmaker known as CSN, reported higher first-quarter 2026 adjusted EBITDA despite heavy rainfall, a stronger Brazilian real and continued pressure from steel ...
National Steel Q1 Earnings Call Highlights
National Steel (NYSE:SID), the Brazilian steelmaker known as CSN, reported higher first-quarter 2026 adjusted EBITDA despite heavy rainfall, a stronger Brazilian real and continued pressure from steel...
Companhia Siderúrgica Nacional Earnings Call Transcript: Q1 2026
EBITDA grew 5.5% year-over-year in Q1 2026, driven by strong cement and logistics performance despite adverse weather and import competition. Leverage improved to 3.36×, asset sales are progressing, and favorable trends are expected in steel and cement for the rest of the year.
Companhia Siderúrgica Nacional Earnings release: Q1 2026
Companhia Siderúrgica Nacional released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
Companhia Siderúrgica Nacional Slides: Q1 2026
Companhia Siderúrgica Nacional has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
Companhia Siderúrgica Nacional Quarterly report: Q1 2026
Companhia Siderúrgica Nacional has published its Q1 2026 quarterly earnings report on May 14, 2026.
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg cells and influence multiple inflammatory pathways. Data supports potential fo...
TRexBio to Present Late-Breaking Data at the Society for Investigative Dermatology (SID) Annual Meeting Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DeepBiology--TRexBio to Present Late-Breaking Data at SID 2026 Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis.
Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting
Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verric...
See How Companhia Siderurgica Nacional Ranks Among Analysts' Top Metals Picks
A study of analyst recommendations at the major brokerages shows that Companhia Siderurgica Nacional (Symbol: SID) is the #31 broker analyst pick, on average, out of the 50 stocks making up the Metals...
CSN announces its Annual Report on Form 20-F for the fiscal year ended December 31, 2025
SÃO PAULO, April 30, 2026 /PRNewswire/ -- Companhia Siderúrgica Nacional (NYSE: SID and B3: CSNA3) ("CSN") has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the...
Shares of SID Now Oversold
In trading on Thursday, shares of Companhia Siderurgica Nacional (Symbol: SID) entered into oversold territory, changing hands as low as $1.19 per share. We define oversold territory using the Relativ...
Companhia Siderúrgica Nacional Earnings Call Transcript: Q4 2025
Record 2025 results driven by mining, logistics, and cost reductions, with EBITDA up 15% year-over-year. Strategic asset sales and deleveraging initiatives are underway to strengthen the balance sheet, while anti-dumping measures and operational efficiencies are expected to boost margins in 2026.
Companhia Siderúrgica Nacional Earnings release: Q4 2025
Companhia Siderúrgica Nacional released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
Companhia Siderúrgica Nacional Slides: Q4 2025
Companhia Siderúrgica Nacional has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.